The use of breast shields is the technique of choice to protect the breasts of women from radiation exposure while undergoing chest CT examinations, according to a new study.
The use of breast shields is the technique of choice to protect the breasts of women from radiation exposure while undergoing chest CT examinations, according to a new study.
Rafel Tappouni, MD, and colleagues at Penn State Hershey Medical Center compared the radiation dose to the front and back of a breast phantom using a breast shield and using posteriorly-centered partial CT.
“We found that posteriorly centered partial CT does decrease skin entrance radiation dose to the breast by 16 percent, but increases overall radiation dose to the chest by 8 percent,” said Tappouni. “The bismuth breast shields, on the other hand, reduced skin entrance dose to the breast by 38 percent without an increase in overall radiation dose,” he said.
Tappouni notes that they now use breast shields at his facility for all female patients up to age 90 who undergo chest CT examinations.
The efficacy of breast shields has a long precedent, but this report specifically compares their use to posteriorly-centered partial CT. Also, the issue has become more important since the International Commission of Radiation Protection (ICRP) increased the tissue weighting factor for the breast from 0.05 to 0.1.
To put the risk into perspective, the delivery of 1 rad to a 35 year-old woman can increase her lifetime risk of breast cancer by 13.6 percent; each CT exam delivers at least twice that amount, Tappouni said.
The study is being presented during the American Roentgen Ray Society Annual Meeting on May 4 in Chicago.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Study Explores Impact of Insurance on Treatment and Referrals for Patients with Uterine Fibroids
February 19th 2025Women with uterine fibroids and Medicaid coverage are significantly more likely to be treated with uterine artery embolization than those with commercial insurance, according to newly published research.